Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy
The term arrhythmogenic cardiomyopathy (ACM) describes a large spectrum of myocardial diseases characterized by progressive fibrotic or fibrofatty replacement, which gives the substrate for the occurrence of ventricular tachyarrhythmias and the development of ventricular dysfunction. This condition may exclusively affect the left ventricle, leading to the introduction of the term arrhythmogenic left ventricular cardiomyopathy (ALVC). The clinical features of ALVC are progressive fibrotic replacement with the absence or mild dilation of the LV and the occurrence of ventricular arrhythmias within the left ventricle. In 2019, the diagnostic criteria for the diagnosis of ALVC, based on family history and clinical, electrocardiographic, and imaging features, have been proposed. However, since the significant clinical and imaging overlap with other cardiac diseases, genetic testing with the demonstration of a pathogenic variant in an ACM-related gene is required for diagnostic confirmation. In ALVC, the multimodality imaging approach comprises different imaging techniques, such as echocardiography, cardiac magnetic resonance, and cardiac nuclear imaging. It provides essential information for the diagnosis, differential diagnosis, sudden cardiac death risk stratification, and management purposes. This review aims to elucidate the current role of the different multimodality imaging techniques in patients with ALVC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Journal of clinical medicine - 12(2023), 4 vom: 16. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Monda, Emanuele [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Arrhythmogenic cardiomyopathy |
|---|
| Anmerkungen: |
Date Revised 01.03.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/jcm12041568 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353422428 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353422428 | ||
| 003 | DE-627 | ||
| 005 | 20231226055946.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm12041568 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1178.xml |
| 035 | |a (DE-627)NLM353422428 | ||
| 035 | |a (NLM)36836107 | ||
| 035 | |a (PII)1568 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Monda, Emanuele |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.03.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a The term arrhythmogenic cardiomyopathy (ACM) describes a large spectrum of myocardial diseases characterized by progressive fibrotic or fibrofatty replacement, which gives the substrate for the occurrence of ventricular tachyarrhythmias and the development of ventricular dysfunction. This condition may exclusively affect the left ventricle, leading to the introduction of the term arrhythmogenic left ventricular cardiomyopathy (ALVC). The clinical features of ALVC are progressive fibrotic replacement with the absence or mild dilation of the LV and the occurrence of ventricular arrhythmias within the left ventricle. In 2019, the diagnostic criteria for the diagnosis of ALVC, based on family history and clinical, electrocardiographic, and imaging features, have been proposed. However, since the significant clinical and imaging overlap with other cardiac diseases, genetic testing with the demonstration of a pathogenic variant in an ACM-related gene is required for diagnostic confirmation. In ALVC, the multimodality imaging approach comprises different imaging techniques, such as echocardiography, cardiac magnetic resonance, and cardiac nuclear imaging. It provides essential information for the diagnosis, differential diagnosis, sudden cardiac death risk stratification, and management purposes. This review aims to elucidate the current role of the different multimodality imaging techniques in patients with ALVC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a arrhythmogenic cardiomyopathy | |
| 650 | 4 | |a cardiac magnetic resonance | |
| 650 | 4 | |a echocardiography | |
| 650 | 4 | |a multimodality imaging | |
| 650 | 4 | |a positron emission tomography | |
| 700 | 1 | |a Rubino, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Palmiero, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Verrillo, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Lioncino, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Diana, Gaetano |e verfasserin |4 aut | |
| 700 | 1 | |a Cirillo, Annapaola |e verfasserin |4 aut | |
| 700 | 1 | |a Fusco, Adelaide |e verfasserin |4 aut | |
| 700 | 1 | |a Dongiglio, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Caiazza, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a Altobelli, Ippolita |e verfasserin |4 aut | |
| 700 | 1 | |a Mauriello, Alfredo |e verfasserin |4 aut | |
| 700 | 1 | |a Guarnaccia, Natale |e verfasserin |4 aut | |
| 700 | 1 | |a Scatteia, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a Cesaro, Arturo |e verfasserin |4 aut | |
| 700 | 1 | |a Pacileo, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Sarubbi, Berardo |e verfasserin |4 aut | |
| 700 | 1 | |a Frisso, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Bauce, Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a D'Andrea, Antonello |e verfasserin |4 aut | |
| 700 | 1 | |a Dellegrottaglie, Santo |e verfasserin |4 aut | |
| 700 | 1 | |a Russo, Maria Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Calabrò, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Limongelli, Giuseppe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 12(2023), 4 vom: 16. Feb. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:4 |g day:16 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm12041568 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 4 |b 16 |c 02 | ||